25 XP   0   0   10

PharmX Technologies Limited
Buy, Hold or Sell?

Let's analyse Pharmx together

PenkeI guess you are interested in PharmX Technologies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmX Technologies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PharmX Technologies Limited

I send you an email if I find something interesting about PharmX Technologies Limited.

Quick analysis of Pharmx (30 sec.)










What can you expect buying and holding a share of Pharmx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
A$0.04
Expected worth in 1 year
A$0.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-19.0%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.0257 - A$0.0332
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Pharmx (5 min.)




Live pricePrice per Share (EOD)

A$0.04

Intrinsic Value Per Share

A$-0.10 - A$-0.02

Total Value Per Share

A$-0.06 - A$0.01

2. Growth of Pharmx (5 min.)




Is Pharmx growing?

Current yearPrevious yearGrowGrow %
How rich?$14.4m$15m-$644.7k-4.5%

How much money is Pharmx making?

Current yearPrevious yearGrowGrow %
Making money-$683k$163.7k-$846.8k-124.0%
Net Profit Margin-17.5%2.1%--

How much money comes from the company's main activities?

3. Financial Health of Pharmx (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Pharmx? (5 min.)

Welcome investor! Pharmx's management wants to use your money to grow the business. In return you get a share of Pharmx.

What can you expect buying and holding a share of Pharmx?

First you should know what it really means to hold a share of Pharmx. And how you can make/lose money.

Speculation

The Price per Share of Pharmx is A$0.035. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.04. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-3.3%0.00-3.3%0.000.8%0.00-2.3%0.00-0.1%
Usd Book Value Change Per Share0.00-3.1%0.00-3.1%0.000.8%0.005.0%0.001.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.001.7%0.002.9%
Usd Total Gains Per Share0.00-3.1%0.00-3.1%0.000.8%0.006.6%0.004.7%
Usd Price Per Share0.02-0.02-0.02-0.03-0.05-
Price to Earnings Ratio-21.03--21.03-80.60-48.29-276.94-
Price-to-Total Gains Ratio-22.28--22.28-74.40-11.52--275.24-
Price to Book Ratio1.00-1.00-0.88-1.55-2.28-
Price-to-Total Gains Ratio-22.28--22.28-74.40-11.52--275.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0227465
Number of shares43962
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (43962 shares)-47.44102.08
Gains per Year (43962 shares)-189.78408.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-190-200103305398
20-380-390206611806
30-569-5803099161214
40-759-77041112221622
50-949-96051415272030
60-1139-115061718332438
70-1328-134072021382846
80-1518-153082324443254
90-1708-172092627493662
100-1898-1910102830554070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%13.013.06.040.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%18.014.00.056.3%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%6.00.04.060.0%11.00.021.034.4%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%18.014.00.056.3%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Pharmx

About PharmX Technologies Limited

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. The company's network connects retail pharmacy and suppliers in Australia and New Zealand. It operates PharmX, an electronic pharmacy ordering gateway; and PharmXchange, a digital sales and marketing platform integrated with PharmX for pharmacies and their suppliers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-02-13 14:44:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of PharmX Technologies Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharmx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Net Profit Margin of -17.5% means that $-0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmX Technologies Limited:

  • The MRQ is -17.5%. The company is making a huge loss. -2
  • The TTM is -17.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17.5%TTM-17.5%0.0%
TTM-17.5%YOY2.1%-19.6%
TTM-17.5%5Y-9.3%-8.2%
5Y-9.3%10Y-3.9%-5.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.5%-20.1%+2.6%
TTM-17.5%-26.7%+9.2%
YOY2.1%-26.8%+28.9%
5Y-9.3%-36.0%+26.7%
10Y-3.9%-47.8%+43.9%
1.1.2. Return on Assets

Shows how efficient Pharmx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • -2.9% Return on Assets means that Pharmx generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmX Technologies Limited:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-2.9%0.0%
TTM-2.9%YOY0.8%-3.7%
TTM-2.9%5Y-5.1%+2.2%
5Y-5.1%10Y-2.1%-3.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-6.0%+3.1%
TTM-2.9%-5.8%+2.9%
YOY0.8%-5.8%+6.6%
5Y-5.1%-6.1%+1.0%
10Y-2.1%-8.2%+6.1%
1.1.3. Return on Equity

Shows how efficient Pharmx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • -4.7% Return on Equity means Pharmx generated $-0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmX Technologies Limited:

  • The MRQ is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-4.7%0.0%
TTM-4.7%YOY1.1%-5.8%
TTM-4.7%5Y-7.9%+3.2%
5Y-7.9%10Y-3.4%-4.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%-4.5%-0.2%
TTM-4.7%-6.8%+2.1%
YOY1.1%-8.3%+9.4%
5Y-7.9%-9.4%+1.5%
10Y-3.4%-9.8%+6.4%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of PharmX Technologies Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmx is operating .

  • Measures how much profit Pharmx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • An Operating Margin of -11.1% means the company generated $-0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmX Technologies Limited:

  • The MRQ is -11.1%. The company is operating very inefficient. -2
  • The TTM is -11.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.1%0.0%
TTM-11.1%YOY3.1%-14.1%
TTM-11.1%5Y13.0%-24.1%
5Y13.0%10Y10.1%+3.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-17.5%+6.4%
TTM-11.1%-9.9%-1.2%
YOY3.1%-24.9%+28.0%
5Y13.0%-17.6%+30.6%
10Y10.1%-31.6%+41.7%
1.2.2. Operating Ratio

Measures how efficient Pharmx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PharmX Technologies Limited:

  • The MRQ is 1.177. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.177. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.177TTM1.1770.000
TTM1.177YOY1.153+0.024
TTM1.1775Y1.120+0.057
5Y1.12010Y1.021+0.099
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1771.291-0.114
TTM1.1771.377-0.200
YOY1.1531.456-0.303
5Y1.1201.398-0.278
10Y1.0211.378-0.357
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of PharmX Technologies Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.84 means the company has $1.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmX Technologies Limited:

  • The MRQ is 1.838. The company is able to pay all its short-term debts. +1
  • The TTM is 1.838. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.838TTM1.8380.000
TTM1.838YOY1.679+0.159
TTM1.8385Y1.770+0.068
5Y1.77010Y1.957-0.186
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8381.643+0.195
TTM1.8381.746+0.092
YOY1.6792.112-0.433
5Y1.7702.588-0.818
10Y1.9572.515-0.558
1.3.2. Quick Ratio

Measures if Pharmx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Quick Ratio of 2.14 means the company can pay off $2.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmX Technologies Limited:

  • The MRQ is 2.139. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.139. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.139TTM2.1390.000
TTM2.139YOY2.365-0.226
TTM2.1395Y1.548+0.591
5Y1.54810Y1.554-0.006
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1391.136+1.003
TTM2.1391.186+0.953
YOY2.3651.695+0.670
5Y1.5481.956-0.408
10Y1.5541.992-0.438
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of PharmX Technologies Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmx to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.39 means that Pharmx assets are financed with 39.2% credit (debt) and the remaining percentage (100% - 39.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmX Technologies Limited:

  • The MRQ is 0.392. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.392. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.392TTM0.3920.000
TTM0.392YOY0.246+0.146
TTM0.3925Y0.310+0.081
5Y0.31010Y0.293+0.017
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3920.439-0.047
TTM0.3920.439-0.047
YOY0.2460.394-0.148
5Y0.3100.430-0.120
10Y0.2930.453-0.160
1.4.2. Debt to Equity Ratio

Measures if Pharmx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmx to the Health Information Services industry mean.
  • A Debt to Equity ratio of 64.4% means that company has $0.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmX Technologies Limited:

  • The MRQ is 0.644. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.644. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.644TTM0.6440.000
TTM0.644YOY0.326+0.318
TTM0.6445Y0.458+0.186
5Y0.45810Y0.421+0.037
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6440.603+0.041
TTM0.6440.612+0.032
YOY0.3260.602-0.276
5Y0.4580.699-0.241
10Y0.4210.622-0.201
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of PharmX Technologies Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pharmx generates.

  • Above 15 is considered overpriced but always compare Pharmx to the Health Information Services industry mean.
  • A PE ratio of -21.03 means the investor is paying $-21.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmX Technologies Limited:

  • The EOD is -19.894. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.031. Based on the earnings, the company is expensive. -2
  • The TTM is -21.031. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.894MRQ-21.031+1.137
MRQ-21.031TTM-21.0310.000
TTM-21.031YOY80.599-101.630
TTM-21.0315Y48.286-69.316
5Y48.28610Y276.936-228.650
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-19.894-1.459-18.435
MRQ-21.031-1.355-19.676
TTM-21.031-1.529-19.502
YOY80.599-3.635+84.234
5Y48.286-4.733+53.019
10Y276.936-4.763+281.699
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmX Technologies Limited:

  • The EOD is -6.225. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.580. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.580. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.225MRQ-6.580+0.356
MRQ-6.580TTM-6.5800.000
TTM-6.580YOY-11.398+4.818
TTM-6.5805Y-8.673+2.092
5Y-8.67310Y-4.583-4.090
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-6.225-1.930-4.295
MRQ-6.580-2.687-3.893
TTM-6.580-3.262-3.318
YOY-11.398-5.734-5.664
5Y-8.673-5.897-2.776
10Y-4.583-3.814-0.769
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharmx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 1.00 means the investor is paying $1.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmX Technologies Limited:

  • The EOD is 0.941. Based on the equity, the company is cheap. +2
  • The MRQ is 0.995. Based on the equity, the company is cheap. +2
  • The TTM is 0.995. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.941MRQ0.995-0.054
MRQ0.995TTM0.9950.000
TTM0.995YOY0.875+0.120
TTM0.9955Y1.554-0.559
5Y1.55410Y2.284-0.730
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD0.9411.412-0.471
MRQ0.9951.612-0.617
TTM0.9951.776-0.781
YOY0.8752.986-2.111
5Y1.5543.961-2.407
10Y2.2844.127-1.843
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PharmX Technologies Limited.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PharmX Technologies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%0.000-463%0.003-162%0.001-269%
Book Value Per Share--0.0370.0370%0.039-4%0.031+21%0.030+24%
Current Ratio--1.8381.8380%1.679+9%1.770+4%1.957-6%
Debt To Asset Ratio--0.3920.3920%0.246+59%0.310+26%0.293+34%
Debt To Equity Ratio--0.6440.6440%0.326+98%0.458+41%0.421+53%
Dividend Per Share----0%-0%0.001-100%0.002-100%
Eps---0.002-0.0020%0.000-517%-0.001-29%0.000-96%
Free Cash Flow Per Share---0.006-0.0060%-0.003-47%-0.005-5%-0.002-57%
Free Cash Flow To Equity Per Share---0.006-0.0060%-0.004-42%-0.001-81%0.000-96%
Gross Profit Margin--1.1641.1640%-0.048+104%0.284+309%-1.561+234%
Intrinsic Value_10Y_max---0.023--------
Intrinsic Value_10Y_min---0.101--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.007--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.023--------
Intrinsic Value_5Y_max---0.012--------
Intrinsic Value_5Y_min---0.043--------
Market Cap20908370.560-6%22103134.59222103134.5920%20310988.544+9%27336201.052-19%41565840.673-47%
Net Profit Margin---0.175-0.1750%0.021-926%-0.093-47%-0.039-78%
Operating Margin---0.111-0.1110%0.031-457%0.130-185%0.101-210%
Operating Ratio--1.1771.1770%1.153+2%1.120+5%1.021+15%
Pb Ratio0.941-6%0.9950.9950%0.875+14%1.554-36%2.284-56%
Pe Ratio-19.894+5%-21.031-21.0310%80.599-126%48.286-144%276.936-108%
Price Per Share0.035-6%0.0370.0370%0.034+9%0.046-19%0.070-47%
Price To Free Cash Flow Ratio-6.225+5%-6.580-6.5800%-11.398+73%-8.673+32%-4.583-30%
Price To Total Gains Ratio-21.077+5%-22.281-22.2810%74.399-130%11.516-293%-275.237+1135%
Quick Ratio--2.1392.1390%2.365-10%1.548+38%1.554+38%
Return On Assets---0.029-0.0290%0.008-451%-0.051+78%-0.021-26%
Return On Equity---0.047-0.0470%0.011-536%-0.079+67%-0.034-29%
Total Gains Per Share---0.002-0.0020%0.000-463%0.004-146%0.003-165%
Usd Book Value--14434928.90014434928.9000%15079629.700-4%11901358.740+21%11599350.210+24%
Usd Book Value Change Per Share---0.001-0.0010%0.000-463%0.002-162%0.001-269%
Usd Book Value Per Share--0.0240.0240%0.025-4%0.020+21%0.019+24%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.001-0.0010%0.000-517%-0.001-29%0.000-96%
Usd Free Cash Flow---2183014.100-2183014.1000%-1158121.800-47%-2070061.480-5%-942225.020-57%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.002-47%-0.003-5%-0.002-57%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%-0.002-42%-0.001-81%0.000-96%
Usd Market Cap13588350.027-6%14364827.17114364827.1710%13200111.455+9%17765797.064-19%27013639.854-47%
Usd Price Per Share0.023-6%0.0240.0240%0.022+9%0.030-19%0.045-47%
Usd Profit---683044.900-683044.9000%163774.800-517%-485735.260-29%-28075.680-96%
Usd Revenue--3911098.2003911098.2000%7748107.800-50%6484702.200-40%8248140.860-53%
Usd Total Gains Per Share---0.001-0.0010%0.000-463%0.002-146%0.002-165%
 EOD+3 -5MRQTTM+0 -0YOY+6 -285Y+11 -2510Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of PharmX Technologies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.894
Price to Book Ratio (EOD)Between0-10.941
Net Profit Margin (MRQ)Greater than0-0.175
Operating Margin (MRQ)Greater than0-0.111
Quick Ratio (MRQ)Greater than12.139
Current Ratio (MRQ)Greater than11.838
Debt to Asset Ratio (MRQ)Less than10.392
Debt to Equity Ratio (MRQ)Less than10.644
Return on Equity (MRQ)Greater than0.15-0.047
Return on Assets (MRQ)Greater than0.05-0.029
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of PharmX Technologies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.774
Ma 20Greater thanMa 500.031
Ma 50Greater thanMa 1000.035
Ma 100Greater thanMa 2000.036
OpenGreater thanClose0.032
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
EBIT  4,009-2,0341,975-4801,495-1,126369-1,034-665
Operating Income  4,009-2,0341,975-4801,495-1,126369-1,034-665
Total Other Income Expense Net -7,9926,475-1,5171,381-13665-71361290
Discontinued Operations  234023402340234-402-168



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets36,520
Total Liabilities14,309
Total Stockholder Equity22,211
 As reported
Total Liabilities 14,309
Total Stockholder Equity+ 22,211
Total Assets = 36,520

Assets

Total Assets36,520
Total Current Assets22,589
Long-term Assets13,931
Total Current Assets
Cash And Cash Equivalents 12,806
Short-term Investments 12,536
Net Receivables 946
Total Current Assets  (as reported)22,589
Total Current Assets  (calculated)26,288
+/- 3,699
Long-term Assets
Property Plant Equipment 47
Goodwill 2,115
Intangible Assets 11,244
Other Assets 525
Long-term Assets  (as reported)13,931
Long-term Assets  (calculated)13,931
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,290
Long-term Liabilities2,019
Total Stockholder Equity22,211
Total Current Liabilities
Short-term Debt 32
Accounts payable 670
Other Current Liabilities 10,671
Total Current Liabilities  (as reported)12,290
Total Current Liabilities  (calculated)11,373
+/- 917
Long-term Liabilities
Other Liabilities 2,019
Long-term Liabilities  (as reported)2,019
Long-term Liabilities  (calculated)2,019
+/-0
Total Stockholder Equity
Common Stock98,405
Retained Earnings -76,253
Other Stockholders Equity 59
Total Stockholder Equity (as reported)22,211
Total Stockholder Equity (calculated)22,211
+/-0
Other
Capital Stock98,405
Cash and Short Term Investments 12,806
Common Stock Shares Outstanding 596,757
Current Deferred Revenue917
Liabilities and Stockholders Equity 36,520
Net Debt -12,774
Net Invested Capital 22,211
Net Tangible Assets 8,852
Net Working Capital 10,299
Property Plant and Equipment Gross 719
Short Long Term Debt Total 32



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
5,284
5,913
6,631
6,606
9,948
14,607
10,644
17,802
14,595
18,033
7,902
23,576
13,699
10,808
10,319
8,011
23,077
26,776
27,013
19,011
19,801
19,888
20,280
25,316
27,244
27,254
26,029
19,757
19,726
15,038
19,178
31,347
30,769
36,520
36,52030,76931,34719,17815,03819,72619,75726,02927,25427,24425,31620,28019,88819,80119,01127,01326,77623,0778,01110,31910,80813,69923,5767,90218,03314,59517,80210,64414,6079,9486,6066,6315,9135,284
   > Total Current Assets 
1,532
2,205
2,306
2,171
2,270
6,867
4,296
7,752
4,352
1,915
1,660
2,790
4,322
2,829
4,605
3,383
5,582
7,548
7,070
5,002
6,062
7,370
8,944
14,111
16,075
14,851
12,670
12,415
11,154
9,188
9,841
10,416
8,586
22,589
22,5898,58610,4169,8419,18811,15412,41512,67014,85116,07514,1118,9447,3706,0625,0027,0707,5485,5823,3834,6052,8294,3222,7901,6601,9154,3527,7524,2966,8672,2702,1712,3062,2051,532
       Cash And Cash Equivalents 
1,017
1,400
1,286
1,771
423
623
119
7,666
4,193
1,167
317
393
1,777
24
1,768
1,614
3,643
3,898
5,400
701
4,764
2,110
3,217
8,884
11,913
12,069
9,577
8,098
4,971
2,333
2,323
6,478
5,759
12,806
12,8065,7596,4782,3232,3334,9718,0989,57712,06911,9138,8843,2172,1104,7647015,4003,8983,6431,6141,768241,7773933171,1674,1937,6661196234231,7711,2861,4001,017
       Short-term Investments 
0
0
0
0
0
796
246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,252
12,536
12,5365,252000000000000000000000000024679600000
       Net Receivables 
515
805
920
400
1,729
4,424
3,595
85
160
569
1,074
1,793
1,608
1,763
2,289
1,330
1,501
3,027
1,353
614
959
527
543
355
158
382
361
393
1,542
2,305
3,826
864
1,085
946
9461,0858643,8262,3051,5423933613821583555435279596141,3533,0271,5011,3302,2891,7631,6081,7931,074569160853,5954,4241,729400920805515
       Other Current Assets 
0
0
100
0
0
174
130
0
0
89
154
3
161
576
414
244
365
521
208
3,542
231
4,627
5,022
4,774
3,882
2,239
2,638
3,775
4,539
2,018
1,822
1,194
1,700
7,178
7,1781,7001,1941,8222,0184,5393,7752,6382,2393,8824,7745,0224,6272313,542208521365244414576161315489001301740010000
   > Long-term Assets 
3,752
3,708
4,325
4,435
7,678
7,740
6,348
10,051
10,243
16,118
6,242
20,786
9,377
7,979
5,714
4,628
17,495
19,228
19,943
14,009
13,739
12,518
11,336
11,205
11,169
12,403
13,359
7,342
8,572
5,850
9,337
20,931
22,183
13,931
13,93122,18320,9319,3375,8508,5727,34213,35912,40311,16911,20511,33612,51813,73914,00919,94319,22817,4954,6285,7147,9799,37720,7866,24216,11810,24310,0516,3487,7407,6784,4354,3253,7083,752
       Property Plant Equipment 
3,752
3,708
4,325
4,313
6,517
6,663
6,348
51
243
651
1,272
1,596
1,377
1,174
780
662
767
907
4,510
2,995
2,778
1,567
383
262
187
294
1,327
981
863
731
1,227
791
603
47
476037911,2277318639811,3272941872623831,5672,7782,9954,5109077676627801,1741,3771,5961,272651243516,3486,6636,5174,3134,3253,7083,752
       Goodwill 
0
0
0
0
893
905
0
0
0
5,467
4,910
11,660
6,071
5,266
4,541
3,826
15,363
15,363
15,363
10,821
10,821
10,821
10,821
10,821
10,821
10,821
10,821
4,544
4,544
0
0
2,115
2,115
2,115
2,1152,1152,115004,5444,54410,82110,82110,82110,82110,82110,82110,82110,82115,36315,36315,3633,8264,5415,2666,07111,6604,9105,4670009058930000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
30
30
30
30
178
2,885
51
148
0
0148512,8851783030303030000000000000000000000000
       Intangible Assets 
0
0
0
0
191
0
0
10,000
10,000
10,000
60
7,530
1,929
1,539
252
3,826
1,270
2,904
14
14
14
12,066
10,821
10,821
10,821
10,821
10,821
837
2,688
4,472
4,674
17,170
18,610
11,244
11,24418,61017,1704,6744,4722,68883710,82110,82110,82110,82110,82112,0661414142,9041,2703,8262521,5391,9297,5306010,00010,00010,000001910000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
60
0
0
0
141
140
65
54
56
179
96
99
102
92
131
1,258
1,181
950
447
617
750
855
855
525
5258558557506174479501,1811,258131921029996179565465140141000600000000000
> Total Liabilities 
979
1,039
1,046
846
1,851
9,206
8,226
325
221
6,282
7,637
10,621
12,522
17,547
23,857
18,677
19,271
19,229
21,904
16,988
16,904
15,240
9,603
8,958
8,370
7,323
6,121
5,781
5,499
5,016
5,981
8,417
7,566
14,309
14,3097,5668,4175,9815,0165,4995,7816,1217,3238,3708,9589,60315,24016,90416,98821,90419,22919,27118,67723,85717,54712,52210,6217,6376,2822213258,2269,2061,8518461,0461,039979
   > Total Current Liabilities 
766
1,039
1,046
846
1,851
8,394
8,044
291
196
6,259
2,494
9,701
12,290
16,415
23,330
12,030
12,424
7,881
21,678
16,752
13,540
14,363
9,215
8,615
7,835
6,993
5,835
5,554
5,230
4,817
5,478
6,387
5,114
12,290
12,2905,1146,3875,4784,8175,2305,5545,8356,9937,8358,6159,21514,36313,54016,75221,6787,88112,42412,03023,33016,41512,2909,7012,4946,2591962918,0448,3941,8518461,0461,039766
       Short-term Debt 
0
0
0
0
0
796
246
0
0
0
0
0
0
4,024
9,706
2,557
6,854
469
11,742
6,919
2,786
2,650
0
0
0
0
0
0
0
0
422
280
303
32
32303280422000000002,6502,7866,91911,7424696,8542,5579,7064,02400000024679600000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
519
2,923
6,897
9,058
8,355
3,946
1,632
1,162
711
679
569
473
439
368
496
548
297
382
447
591
361
435
841
670
6708414353615914473822975484963684394735696797111,1621,6323,9468,3559,0586,8972,9235190000000000
       Other Current Liabilities 
766
1,039
1,046
680
1,141
5,171
6,622
15
26
5,438
1,974
6,778
4,538
2,463
5,269
5,528
2,062
4,452
7,189
9,076
9,657
10,694
8,297
7,686
6,896
6,141
5,296
4,970
4,595
4,080
4,469
5,572
3,887
10,671
10,6713,8875,5724,4694,0804,5954,9705,2966,1416,8967,6868,29710,6949,6579,0767,1894,4522,0625,5285,2692,4634,5386,7781,9745,43826156,6225,1711,1416801,0461,039766
   > Long-term Liabilities 
213
0
0
0
0
812
182
34
25
23
5,143
920
232
1,132
527
6,647
6,847
11,348
226
236
3,364
877
388
343
535
330
286
227
269
199
503
2,030
2,452
2,019
2,0192,4522,0305031992692272863305353433888773,36423622611,3486,8476,6475271,1322329205,1432325341828120000213
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311
41
23
0
02341311000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
23
49
29
49
98
93
147
117
158
206
164
177
388
343
535
330
286
227
269
199
192
1,989
2,429
2,019
2,0192,4291,9891921992692272863305353433881771642061581171479398492949230000000000
> Total Stockholder Equity
4,305
4,874
5,585
5,760
8,097
5,401
2,418
17,477
14,375
11,751
265
12,955
1,177
-8,959
-13,538
-10,666
3,806
7,547
5,109
2,023
2,897
4,648
10,677
16,358
18,874
19,931
19,908
13,976
14,227
10,022
13,197
22,930
23,203
22,211
22,21123,20322,93013,19710,02214,22713,97619,90819,93118,87416,35810,6774,6482,8972,0235,1097,5473,806-10,666-13,538-8,9591,17712,95526511,75114,37517,4772,4185,4018,0975,7605,5854,8744,305
   Common Stock
588
588
588
588
666
779
3,353
16,136
16,136
35,080
36,460
55,164
61,040
61,315
65,267
73,462
74,107
77,223
77,835
85,219
85,219
85,219
85,219
85,795
86,223
86,283
86,283
86,283
86,283
86,283
89,724
98,366
98,366
98,405
98,40598,36698,36689,72486,28386,28386,28386,28386,28386,22385,79585,21985,21985,21985,21977,83577,22374,10773,46265,26761,31561,04055,16436,46035,08016,13616,1363,353779666588588588588
   Retained Earnings 
1,382
1,950
2,063
2,238
2,156
-7,324
-14,332
-17,053
-20,156
-23,330
-36,195
-44,428
-62,068
-70,274
-78,805
-84,129
-70,314
-69,906
-73,027
-83,515
-82,577
-80,805
-74,772
-69,784
-68,462
-66,603
-66,465
-72,307
-72,056
-76,261
-76,545
-75,454
-75,202
-76,253
-76,253-75,202-75,454-76,545-76,261-72,056-72,307-66,465-66,603-68,462-69,784-74,772-80,805-82,577-83,515-73,027-69,906-70,314-84,129-78,805-70,274-62,068-44,428-36,195-23,330-20,156-17,053-14,332-7,3242,1562,2382,0631,9501,382
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
2,335
2,336
2,934
3,816
5,275
12,820
13,919
18,394
18,406
46
152
3,209
3,826
0
0
0
0
0
0
0
0
0
0
0
1,113
251
90
0
1,814
2,208
18
18
39
59
593918182,2081,8140902511,113000000000003,8263,2091524618,40618,39413,91912,8205,2753,8162,9342,3362,335



Balance Sheet

Currency in AUD. All numbers in thousands.